Editorial: Co-morbidity of COVID 19 and fungal infections
- PMID: 39351259
- PMCID: PMC11439790
- DOI: 10.3389/ffunb.2024.1462172
Editorial: Co-morbidity of COVID 19 and fungal infections
Keywords: COVID-19; clinical management; co-morbidity; fungal infections; morbidity and mortality.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Co-morbidity of COVID 19 and fungal infections
References
-
- Dutt Y., Pandey R. P., Dutt M., Gupta A., Vibhuti A., Raj V.S., et al. . (2023). Liposomes and phytosomes: Nanocarrier systems and their applications for the delivery of phytoconstituents. Coordination Chem. Rev. 491, 215251. doi: 10.1016/j.ccr.2023.215251 - DOI
Publication types
LinkOut - more resources
Full Text Sources